This content is from: Portfolio Ackman’s Pershing Square Posts More Losses as Recession Fears Overtake Inflation Worries The fund’s performance was hurt both by stock price declines and an abrupt downward shift in interest rates. By Michelle Celarier July 05, 2022
This content is from: Portfolio Bill Ackman Gets Pummeled in April Pershing Square’s big Netflix loss was only part of Ackman’s problems, as the NYSE pulled plans to list warrants for his proposed SPARC. By Michelle Celarier May 03, 2022
Sponsored Valeant Looks To Refinance Loans Valeant Pharmaceuticals International Inc. is seeking to refinance the existing senior secured credit facilities of its wholly owned subsidiary Valeant Pharmaceuticals International. September 21, 2011
This content is from: Portfolio Valeant Pharmaceuticals' Acquisitions Should Please Jeff Ubben Valeant Pharmaceuticals' share price has quadrupled since 2008 thanks to its growth-by-acquisition strategy. By Stephen Taub September 04, 2012
Sponsored Valeant To Buy PharmaSwiss For €350M Canadian specialty pharmaceutical company, Valeant Pharmaceuticals International, will acquire PharmaSwiss for €350 million. February 02, 2011
Sponsored Valeant Offers $5.7B For Cephalon Ontario-based Valeant Pharmaceuticals International is seeking to acquire drug maker, Cephalon, for nearly $5.7 billion. March 29, 2011
